Navid Ahmadi

1.4k total citations
11 papers, 314 citations indexed

About

Navid Ahmadi is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Navid Ahmadi has authored 11 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Navid Ahmadi's work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (2 papers) and Immunotherapy and Immune Responses (2 papers). Navid Ahmadi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (2 papers) and Immunotherapy and Immune Responses (2 papers). Navid Ahmadi collaborates with scholars based in Poland, United Kingdom and Bulgaria. Navid Ahmadi's co-authors include Κimon Stamatelopoulos, Stefano Figliozzi, Pier Giorgio Masci, Lara Tondi, Meletios Α. Dimopoulos, Alberto Aimo, Alida L.P. Caforio, Evangelia Koutli, Georgios Georgiopoulos and Łukasz Szylberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ Open and European Journal of Clinical Investigation.

In The Last Decade

Navid Ahmadi

9 papers receiving 306 citations

Peers

Navid Ahmadi

ID

NEURO

ONCOL

MB

EPIDE

Lara Tondi Italy

Ding Long China

Yihe Yang United States

Benjamin D Clarke United Kingdom

Christopher Fung United States

Sahar Memar Montazerin United States

Ranine Ghamrawi United States

Ellie J. Coromilas United States

Olynka Vega‐Vega Mexico

Gi Hwan Bae South Korea

Lara Tondi Italy

Navid Ahmadi

165 ×1.0

ID

92 ×1.0

NEURO

58 ×0.7

ONCOL

36 ×0.9

MB

50 ×1.4

EPIDE

Citations per year, relative to Navid Ahmadi Navid Ahmadi (= 1×) peers Lara Tondi

Countries citing papers authored by Navid Ahmadi

Since Specialization

Citations

This map shows the geographic impact of Navid Ahmadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Ahmadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Ahmadi more than expected).

Fields of papers citing papers by Navid Ahmadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Ahmadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Ahmadi. The network helps show where Navid Ahmadi may publish in the future.

Co-authorship network of co-authors of Navid Ahmadi

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Ahmadi. A scholar is included among the top collaborators of Navid Ahmadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Ahmadi. Navid Ahmadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ahmadi, Navid, et al.. (2023). Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review. SHILAP Revista de lepidopterología. 24(1). 14–29. 12 indexed citations

2.

Ahmadi, Navid, et al.. (2022). CDK9 inhibitors in multiple myeloma: a review of progress and perspectives. Medical Oncology. 39(4). 39–39. 21 indexed citations

3.

McKie, Mikel A., et al.. (2022). Multicentre evaluation of renal impairment in thoracic surgery (MERITS): a retrospective cohort study. BMJ Open. 12(9). e058542–e058542.

4.

Ahmadi, Navid, et al.. (2022). Clinical significancy of WNT pathway inhibition in various cancers. SHILAP Revista de lepidopterología. 12(11). 183–191. 1 indexed citations

5.

Ahmadi, Navid, et al.. (2021). When Is Immunohistochemistry Useful in Assessing Tumor Necrotic Tissue?. Anticancer Research. 41(1). 197–201. 5 indexed citations

6.

Antosik, Paulina, et al.. (2021). The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clinics and Research in Hepatology and Gastroenterology. 45(3). 101664–101664. 17 indexed citations

7.

Ahmadi, Navid, et al.. (2021). Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy. Current Cancer Drug Targets. 21(11). 919–931.

8.

Antosik, Paulina, et al.. (2020). The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer. Journal of Cancer Research and Clinical Oncology. 146(10). 2547–2557. 10 indexed citations

9.

Ahmadi, Navid, et al.. (2020). Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature. Endokrynologia Polska. 71(5). 466–478. 21 indexed citations

10.

Figliozzi, Stefano, Pier Giorgio Masci, Navid Ahmadi, et al.. (2020). Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis. European Journal of Clinical Investigation. 50(10). e13362–e13362. 226 indexed citations

11.

Perek, Bartłomiej, Bartosz Kempisty, Mariusz J. Nawrocki, et al.. (2019). Infiltration of CD68+ cells correlates positively with matrix metalloproteinase 2 expression in the arteries used as aortocoronary bypass grafts. Possible clinical implications. Cardiology Journal. 27(6). 817–824. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact